Medication therapy management (MTM) is a set of services, typically provided by a pharmacist, designed to make sure every medication you take is working properly, necessary, and not causing problems. It’s most commonly associated with Medicare Part D, which requires all prescription drug plans to offer MTM to eligible beneficiaries at no extra cost. But MTM programs also exist through Medicaid, private insurers, and self-insured employers.
The core idea is simple: the more medications you take, the higher the chance something goes wrong. Drugs can interact with each other, doses can drift out of range, or you might be taking something you no longer need. MTM exists to catch those problems before they lead to an emergency room visit.
What Happens During MTM
MTM includes two main types of service. The first is a comprehensive medication review (CMR), which is a thorough, one-on-one conversation between you and a pharmacist about every medication you take, including prescriptions, over-the-counter drugs, and supplements. This review covers your chronic conditions, how you’re taking each medication, whether anything is causing side effects, and whether your treatment goals are being met. CMRs are offered at least once a year and can happen in person or by phone. They typically take longer than a standard pharmacy interaction, sometimes 30 minutes or more.
The second type is a targeted medication review (TMR), which is narrower in scope. Instead of reviewing everything, a TMR zeroes in on a specific issue: a potential drug interaction, a gap in monitoring, or a medication you may not be taking consistently. These happen at least quarterly and serve as ongoing check-ins between your annual comprehensive reviews.
Research comparing the two approaches found that targeted reviews take about 10 minutes less per patient than comprehensive ones. Interestingly, prescribers are more likely to approve medication changes that come out of targeted reviews, possibly because the recommendations are more focused and specific.
What You Receive
After a comprehensive medication review, you’ll get two documents. The first is a Personal Medication List, which is essentially a master record of everything you’re taking. It includes each drug’s name and strength, how to take it, why you’re taking it, when you started, and which doctor prescribed it. It also lists your known allergies and any past adverse reactions. This is the document you’d bring to a new doctor’s appointment or an emergency room visit.
The second document is a Medication Action Plan. This is a to-do list that comes out of your conversation with the pharmacist. It lists specific concerns that were discussed (for example, “blood sugar readings have been high”) and the steps you should take in response (“talk to your doctor about adjusting your insulin dose” or “start checking blood sugar before meals”). There’s also space for you to track what you actually did and when. The action plan is designed to keep you engaged in managing your own health between visits.
Who Qualifies Under Medicare
Every Medicare Part D plan must offer MTM, but each plan sets its own eligibility criteria within limits established by CMS. To qualify, you generally need to meet three thresholds simultaneously: a minimum number of chronic conditions, a minimum number of covered medications, and a minimum annual drug cost.
Plans can require two or three chronic conditions as the minimum (they cannot set it higher than three). For medications, plans can require anywhere from two to eight covered Part D drugs. And for 2025, the annual drug cost threshold is $1,623, dropping to $1,276 for 2026. If your total annual spending on Part D medications meets or exceeds that amount, you clear the cost bar.
The qualifying chronic conditions vary by plan but typically include common diseases that require ongoing medication management: diabetes, heart failure, high blood pressure, COPD, high cholesterol, and similar conditions. If your plan determines you’re eligible, they’re required to enroll you and offer these services at no additional cost.
What Pharmacists Actually Look For
During an MTM encounter, the pharmacist is screening for a range of medication-related problems. These include untreated conditions (you have a diagnosis but aren’t on the right drug), doses that are too high or too low, duplicate therapies (two drugs doing the same thing), drug-drug interactions, complicated dosing schedules that make adherence difficult, and use of medications flagged as potentially inappropriate for older adults.
Non-adherence is one of the most common issues. Sometimes the fix is straightforward: simplifying a complicated schedule, switching to a once-daily version of a drug, or identifying a side effect that’s been quietly discouraging you from taking a medication. When the pharmacist identifies a change that needs a prescriber’s involvement, they send a recommendation to your doctor. You don’t need to coordinate that yourself.
Impact on Health Outcomes
The evidence on MTM’s effectiveness is strongest for people with chronic conditions who take multiple medications. A 2010 analysis of Medicare beneficiaries found that MTM participants with heart failure had adherence rates 11 to 40 percent higher than similar patients not in MTM programs. For people with COPD, adherence was 11 to 26 percent higher. For diabetes, 15 to 35 percent higher.
Better adherence translates to fewer crises. One landmark community pharmacy program, the Asheville Project, tracked asthma patients enrolled in MTM-style services and found that hospitalizations dropped from 4 percent to 1.9 percent and emergency department visits fell from 9 percent to 1.3 percent. A study of Medicaid patients with asthma saw a 76 percent decrease in ER visits after enrollment. A randomized trial of telephone-based MTM among new Medicare home health patients found they were three times less likely to be hospitalized within 60 days compared to a control group.
For people with diabetes or heart failure specifically, MTM interventions lowered the odds of hospitalization across multiple studies. Patients with heart failure who received MTM had roughly half the hospitalization risk of those who didn’t.
Cost Savings
MTM programs consistently show positive returns, though the magnitude varies. One study of a Minnesota health plan found that total health spending dropped from nearly $12,000 per person in the year before MTM enrollment to just over $8,000 in the year after. Another estimated a return of $1.29 for every dollar spent on MTM administration, with an average cost of $67 per encounter and $86 in savings per encounter over a 10-year period.
The Pennsylvania Project, which used community pharmacists to deliver MTM-style interventions, reported reduced annual healthcare spending per patient ranging from $241 for those on cholesterol-lowering drugs to $341 for those on oral diabetes medications. A 2013 study of a self-insured employer found that both medical costs and total expenditures dropped among employees who received MTM compared to those who didn’t, producing a positive return on investment for the employer.
How to Access MTM Services
If you’re on Medicare Part D, your plan is required to contact you if you’re eligible. This outreach often comes as a phone call or letter, and it’s worth responding to rather than dismissing it as a sales pitch. The services are free to you.
Outside of Medicare, access depends on your insurer or employer. Some commercial plans and Medicaid programs offer MTM through community pharmacies, health system pharmacies, or dedicated call centers. You can also ask your pharmacist directly whether they provide MTM services. Many community pharmacies do, and some states allow pharmacists to bill for MTM under Medicaid.
MTM sessions are billed in 15-minute increments and can last up to one hour. The first 15 minutes covers the initial assessment, and additional time is added as needed. Whether the session happens in person or over the phone, the goal is the same: making sure your medications are helping you, not working against you.